EST database searching has led to the cloning and characterization of a number of proteins belonging to the tumor necrosis factor (TNF) and TNF receptor (TNF–R) families. Although structurally related ...

A new review in Molecular Biology Reports argues that DNA methylation silencing of the TRAIL pathway components DR5, DcR2, ...

Phase Ib/II study of fruquintinib plus 5-fluorouracil/leucovorin after progression on fruquintinib monotherapy in metastatic colorectal cancer. Genetic mutations and ...

68Ga-HER2 affibody PET/CT imaging as an option in patients whose HER2 status of any tumor in the body needs to be deciphered. This is an ASCO Meeting Abstract from the 2021 ASCO Annual Meeting I. This ...

A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical study from researchers in the Perelman School of Medicine at the University ...

A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical study. The experimental approach, which uses tiny capsules called small ...

Home » DR5 as promising CAR T-cell target allowing inhibition of tumor cells and MDSCs To read the full story, subscribe or sign in. Immuno-oncology ...

Small extracellular vesicles (sEVs) are nanoscale membranous particles that have emerged as targets for liquid biopsy and as promising drug delivery vehicles. They can serve as biomarkers for tumor ...

A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical study from researchers in the Perelman School of Medicine at the University ...

University of Pennsylvania researchers investigated death receptor 5 (DR5 or CD262) as a chimeric antigen receptor (CAR) target for solid tumors.

HexaBody-DR5/DR5（GEN1029）是一种由两种人源化免疫球蛋白G1（IgG1）抗体Hx-DR5-01和Hx-DR5-05组成的死亡受体5（DR5）激动剂，可非重叠 ...